Financial Information

Cash Flow

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES    
Net (loss) attributable to Immudyne, Inc. $ (1,205,961) $ (1,107,544)
Net (loss) attributable to noncontrolling interests (12,488) (115,749)
Net (Loss) (1,218,449) (1,223,293)
Adjustments to reconcile net (loss) to net cash (used) by operating activities    
Change in fair value of derivative liability (502,830)
Bad debt provision (recovery) (49,119) 71,136
Amortization of debt discount 91,557 33,715
Loss on settlement of notes and other payables 553,222
Stock compensation expense 162,741 587,991
Common stock issued for services 838,938
Changes in Assets and Liabilities    
Trade accounts receivable 95,092 (361,443)
Other receivables 2,250 (2,250)
Product deposit (16,500)
Inventory (546,891) (99,219)
Accounts payable and accrued expenses (227,227) 585,449
Net cash (used) by operating activities (817,216) (407,914)
CASH FLOWS FROM FINANCING ACTIVITIES    
Investment in subsidiary by noncontrolling interest, net 63,378 219,894
Proceeds from notes payable 878,855 200,000
Proceeds from convertible note payable 100,000
Repayment of convertible note payable (100,000)
Repayment of notes payable (662,796) (168,600)
Proceeds from options exercise 30,000
Sale of common stock and warrants 673,245 63,250
Purchase of treasury stock (76,648) (87,053)
Net cash provided by financing activities 776,034 357,491
Net increase in cash (41,182) (50,423)
Cash at beginning of the period 182,561 232,984
Cash at end of the period 141,379 182,561
Supplemental Disclosure of Cash Flow Information    
Cash paid during the period for interest 4,723 13,650
Issuance of company stock for notes and other payables 242,192
Issuance of common stock in relation to debt offering 58,750
Issuance of common stock for services 100,000
Conversion of equity invested in subsidiary to common stock and warrants 303,419
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance $ 261,357 $ 192,254

Source